Yentli Soto Albrecht has a rare genetic form of ALS and is working on research at Penn that could one day prove life-saving.
Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...
A team of University of Kentucky researchers has uncovered a surprising clue in the battle against Alzheimer's disease that could help doctors predict, and ultimately prevent, a common side effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results